SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-20-002257
Filing Date
2020-04-01
Accepted
2020-04-01 16:16:22
Documents
2
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7577
2 EXHIBIT 24.1 exh_241.htm EX-24.1 8658
  Complete submission text file 0001171843-20-002257.txt   17577
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 PROMENADE DU CENTROPOLIS SUITE 100 LAVAL A8 H7T 0A3
Business Address
Boily Jean-Francois (Reporting) CIK: 0001807042 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 20765585